Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-22-004615
Filing Date
2022-02-03
Accepted
2022-02-03 16:41:20
Documents
2
Period of Report
2022-02-02

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2141
2 EX-24 DOCUMENT attachment1.htm EX-24 4613
  Complete submission text file 0000899243-22-004615.txt   8091
Mailing Address ONE BROADWAY, 14TH FLOOR CAMBRIDGE MA 02142
Business Address ONE BROADWAY, 14TH FLOOR CAMBRIDGE MA 02142 508-446-2272
Nuvalent, Inc. (Issuer) CIK: 0001861560 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O NUVALENT, INC. ONE BROADWAY 14TH FLOOR CAMBRIDGE MA 02142
Business Address
Conley Emily (Reporting) CIK: 0001907812 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40671 | Film No.: 22588989